Vanguard Group Inc I Teos Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,656,810 shares of ITOS stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,656,810

Previous 2,050,006 19.18%

Holding current value

$12 Million

Previous $30.4 Million 44.4%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.09 - $17.97 $3.97 Million - $7.07 Million	-393,196 Reduced 19.18%	1,656,810 $16.9 Million
Q2 2024 Aug 13, 2024	BUY	$10.33 - $18.09 $5.68 Million - $9.94 Million	549,404 Added 36.61%	2,050,006 $30.4 Million
Q1 2024 May 10, 2024	BUY	$9.89 - $13.64 $95,537 - $131,762	9,660 Added 0.65%	1,500,602 $20.5 Million
Q4 2023 Feb 14, 2024	SELL	$8.57 - $11.06 $2.77 Million - $3.57 Million	-322,817 Reduced 17.8%	1,490,942 $16.3 Million
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $442,456 - $589,942	40,407 Added 2.28%	1,813,759 $19.9 Million
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.05 $4,693 - $6,552	363 Added 0.02%	1,773,352 $23.5 Million
Q1 2023 May 15, 2023	SELL	$13.02 - $22.62 $599,453 - $1.04 Million	-46,041 Reduced 2.53%	1,772,989 $24.1 Million
Q4 2022 Feb 10, 2023	BUY	$17.77 - $21.6 $1.21 Million - $1.47 Million	67,930 Added 3.88%	1,819,030 $35.5 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $2.26 Million - $3.31 Million	121,514 Added 7.46%	1,751,100 $33.4 Million
Q2 2022 Aug 12, 2022	BUY	$16.57 - $35.1 $2.54 Million - $5.39 Million	153,544 Added 10.4%	1,629,586 $33.6 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $13.3 Million - $19.7 Million	415,232 Added 39.14%	1,476,042 $47.5 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $11.6 Million - $21.1 Million	441,779 Added 71.37%	1,060,810 $49.4 Million
Q3 2021 Nov 12, 2021	BUY	$23.91 - $29.58 $2.49 Million - $3.08 Million	104,056 Added 20.21%	619,031 $16.7 Million
Q2 2021 Aug 13, 2021	BUY	$17.9 - $36.1 $9.22 Million - $18.6 Million	514,975 New	514,975 $13.2 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $258M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc I Teos Therapeutics, Inc. Transaction History